Adverse drug reactions caused by drug-drug interactions reported to Croatian Agency for Medicinal Products and Medical Devices: a retrospective observational study

被引:29
|
作者
Skvrce, Nikica Miroevic [1 ]
Sarinic, Viola Macolic [1 ]
Mucalo, Iva [2 ]
Krnic, Darko [1 ]
Bozina, Nada [3 ,4 ]
Tomic, Sinisa
机构
[1] Agcy Med Prod & Med Devices, Pharmacovigilance Dept, Zagreb, Croatia
[2] Univ Zagreb, Ctr Appl Chem, Fac Pharm & Biochem, Zagreb 41000, Croatia
[3] Univ Sch Med, Dept Lab Diagnost, Zagreb, Croatia
[4] Univ Hosp Ctr, Zagreb, Croatia
关键词
EMERGENCY-DEPARTMENT VISITS; HOSPITAL-ADMISSIONS; ELDERLY PATIENTS; CLINICAL-RELEVANCE; DETECTING SIGNALS; POTENTIAL RISKS; DATABASE; EVENTS; PREVENTION; PHARMACOVIGILANCE;
D O I
10.3325/cmj.2011.52.604
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim To analyze potential and actual drug-drug interactions reported to the Spontaneous Reporting Database of the Croatian Agency for Medicinal Products and Medical Devices (HALMED) and determine their incidence. Methods In this retrospective observational study performed from March 2005 to December 2008, we detected potential and actual drug-drug interactions using interaction programs and analyzed them. Results HALMED received 1209 reports involving at least two drugs. There were 468 (38.7%) reports on potential drug-drug interactions, 94 of which (7.8% of total reports) were actual drug-drug interactions. Among actual drug-drug interaction reports, the proportion of serious adverse drug reactions (53 out of 94) and the number of drugs (n = 4) was significantly higher (P < 0.001) than among the remaining reports (580 out of 1982; n = 2, respectively). Actual drug-drug interactions most frequently involved nervous system agents (34.0%), and interactions caused by antiplatelet, anticoagulant, and non-steroidal anti-inflammatory drugs were in most cases serious. In only 12 out of 94 reports, actual drug-drug interactions were recognized by the reporter. Conclusion The study confirmed that the Spontaneous Reporting Database was a valuable resource for detecting actual drug-drug interactions. Also, it identified drugs leading to serious adverse drug reactions and deaths, thus indicating the areas which should be in the focus of health care education.
引用
收藏
页码:604 / 614
页数:11
相关论文
共 50 条
  • [1] Epidemiology and characteristics of adverse drug reactions caused by drug-drug interactions
    Magro, Lara
    Moretti, Ugo
    Leone, Roberto
    EXPERT OPINION ON DRUG SAFETY, 2012, 11 (01) : 83 - 94
  • [2] Adverse drug reactions caused by drug-drug interactions in elderly outpatients: a prospective cohort study
    Obreli-Neto, Paulo Roque
    Nobili, Alessandro
    Baldoni, Andre de Oliveira
    Guidoni, Camilo Molino
    de Lyra Junior, Divaldo Pereira
    Pilger, Diogo
    Duzanski, Juliano
    Tettamanti, Mauro
    Cruciol-Souza, Joice Mara
    Gaeti, Walderez Penteado
    Nakamura Cuman, Roberto Kenji
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 68 (12) : 1667 - 1676
  • [3] Adverse drug reactions and correlations with drug-drug interactions: A retrospective study of reports from 2011 to 2020
    Jiang, Huaqiao
    Lin, Yanhua
    Ren, Weifang
    Fang, Zhonghong
    Liu, Yujuan
    Tan, Xiaofang
    Lv, Xiaoqun
    Zhang, Ning
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [4] Understanding adverse drug reactions in older adults through drug-drug interactions
    Marengoni, A.
    Pasina, L.
    Concoreggi, C.
    Martini, G.
    Brognoli, F.
    Nobili, A.
    Onder, G.
    Bettoni, D.
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2014, 25 (09) : 843 - 846
  • [5] Drug-drug interactions with imatinib: An observational study
    Recoche, Isabelle
    Rousseau, Vanessa
    Bourrel, Robert
    Lapeyre-Mestre, Maryse
    Chebane, Leila
    Despas, Fabien
    Montastruc, Jean-Louis
    Bondon-Guitton, Emmanuelle
    MEDICINE, 2016, 95 (40)
  • [6] The importance of drug-drug interactions as a cause of adverse drug reactions: a pharmacovigilance study of serotoninergic reuptake inhibitors in France
    Montastruc, Francois
    Sommet, Agnes
    Bondon-Guitton, Emmanuelle
    Durrieu, Genevieve
    Bui, Eric
    Bagheri, Haleh
    Lapeyre-Mestre, Maryse
    Schmitt, Laurent
    Montastruc, Jean-Louis
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 68 (05) : 767 - 775
  • [7] Potential drug-drug interactions and adverse drug reactions in patients with liver cirrhosis
    Franz, Carmen C.
    Egger, Sabin
    Born, Christa
    Bravo, Alexandra E. Raetz
    Kraehenbuehl, Stephan
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 68 (02) : 179 - 188
  • [8] Drug-drug interactions and adverse drug reactions: separating the wheat from the chaff
    Pirmohamed, Munir
    WIENER KLINISCHE WOCHENSCHRIFT, 2010, 122 (3-4) : 62 - 64
  • [9] A 6-year retrospective study of adverse drug reactions due to drug-drug interactions between nervous system drugs
    Shi, Qing-ping
    He, Xian-di
    Yu, Mei-ling
    Zhu, Jin-xiu
    Liu, Yan
    Ding, Feng
    Sang, Rang
    Jiang, Xiao-dong
    Zhang, Shu-qiang
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2014, 52 (05) : 392 - 401
  • [10] Prospective Observational Evaluation of Incidences and Implications of Drug-Drug Interactions Induced Adverse Drug Reactions in Critically Ill Patients
    Ray, S.
    Pramanik, J.
    Bhattacharyya, M.
    Todi, S.
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2010, 72 (06) : 787 - U126